← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Cross Country Healthcare's FY2025 revenue fell and losses widened, even though FCF stayed positive and the forensic screen was clean.
The read at a glance✓ Audited against SEC data
- Business mix — Healthcare staffingNote
- Revenue — $1.054B, -21.6%Watch
- Net income — ($94.9M), lossWatch
- FCF — $40.1M, -64.0%Note
- Equity — $322.8M, -22.9%Watch
- Insiders — $39.2K purchase and 1 saleNote
- Accounting — Altman safe; Beneish clean; EQ safeOK
Business
Cross Country Healthcare provides healthcare workforce solutions, staffing, advisory services, and the Intellify workforce-management platform.
Where the revenue comes from
Fiscal 2025, as CROSS COUNTRY HEALTHCARE INC reports it. History and quarterly detail are in the app.
- Nurse And Allied Staffing$862.8M
- Physician Staffing$191.5M
Leadership changes
From CROSS COUNTRY HEALTHCARE INC's own filings, the day they're filed.
- Marvin Veizaga · President · appointmenteff. 2026-03-09
- Phil Noe · Chief Information Officer · departureeff. 2026-03-09
- Kevin C. Clark · CEO · appointmenteff. 2025-12-15
Latest filings
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-07-17
- 8-K · Company announcement2026-07-06
- 8-K · Company announcement2026-06-23
- 10-Q · Quarterly report2026-05-08
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CROSS COUNTRY HEALTHCARE INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.